Ocugen Inc (OCGN)
1.33
+0.01
(+0.76%)
USD |
NASDAQ |
May 03, 16:00
1.37
+0.04
(+3.01%)
After-Hours: 20:00
Ocugen Enterprise Value: 305.59M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 305.59M |
May 02, 2024 | 303.01M |
May 01, 2024 | 321.03M |
April 30, 2024 | 303.01M |
April 29, 2024 | 321.03M |
April 26, 2024 | 292.72M |
April 25, 2024 | 266.99M |
April 24, 2024 | 266.99M |
April 23, 2024 | 285.00M |
April 22, 2024 | 282.43M |
April 19, 2024 | 303.01M |
April 18, 2024 | 303.01M |
April 17, 2024 | 333.89M |
April 16, 2024 | 372.49M |
April 15, 2024 | 372.49M |
April 12, 2024 | 403.37M |
April 11, 2024 | 398.22M |
April 10, 2024 | 426.52M |
April 09, 2024 | 403.37M |
April 08, 2024 | 445.68M |
April 05, 2024 | 432.86M |
April 04, 2024 | 350.75M |
April 03, 2024 | 349.47M |
April 02, 2024 | 317.40M |
April 01, 2024 | 358.45M |
Date | Value |
---|---|
March 28, 2024 | 384.11M |
March 27, 2024 | 420.03M |
March 26, 2024 | 407.20M |
March 25, 2024 | 432.86M |
March 22, 2024 | 384.11M |
March 21, 2024 | 307.14M |
March 20, 2024 | 281.48M |
March 19, 2024 | 245.56M |
March 18, 2024 | 227.60M |
March 15, 2024 | 240.43M |
March 14, 2024 | 225.04M |
March 13, 2024 | 230.17M |
March 12, 2024 | 215.80M |
March 11, 2024 | 205.10M |
March 08, 2024 | 216.83M |
March 07, 2024 | 222.47M |
March 06, 2024 | 186.55M |
March 05, 2024 | 184.76M |
March 04, 2024 | 189.12M |
March 01, 2024 | 209.64M |
February 29, 2024 | 203.49M |
February 28, 2024 | 204.79M |
February 27, 2024 | 217.34M |
February 26, 2024 | 194.25M |
February 23, 2024 | 167.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.722M
Minimum
Nov 22 2019
3.066B
Maximum
May 03 2021
403.11M
Average
118.76M
Median
Mar 31 2023
Enterprise Value Benchmarks
QuidelOrtho Corp | 5.088B |
Johnson & Johnson | 366.66B |
Akebia Therapeutics Inc | 278.90M |
Shockwave Medical Inc | 12.10B |
iBio Inc | 16.80M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -9.493M |
Revenue (Quarterly) | 6.036M |
Total Expenses (Quarterly) | 14.66M |
EPS Diluted (Quarterly) | -0.04 |
Profit Margin (Quarterly) | -157.3% |
Earnings Yield | -20.30% |
Normalized Earnings Yield | -20.30 |